4//SEC Filing
MICLOT JOHN L 4
Accession 0001235802-20-000010
CIK 0001492658other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:24 PM ET
Size
9.4 KB
Accession
0001235802-20-000010
Insider Transaction Report
Form 4
MICLOT JOHN L
Director
Transactions
- Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2020-02-28$17.82/sh+10,309$183,706→ 55,440 total - Sale
Ordinary Shares, par value EUR 0.03 per share
2020-02-28$30.13/sh−10,309$310,560→ 45,131 total - Exercise/Conversion
Stock Option (right to buy)
2020-02-28−10,309→ 0 totalExercise: $17.82Exp: 2020-05-13→ Ordinary Shares (10,309 underlying)
Footnotes (4)
- [F1]The reporting person exercised this option because the option was in the money and scheduled to expire on May 13, 2020.
- [F2]Includes 3,916 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.06 to $30.16, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]This option has fully vested.
Documents
Issuer
Wright Medical Group N.V.
CIK 0001492658
Entity typeother
Related Parties
1- filerCIK 0001186473
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:24 PM ET
- Size
- 9.4 KB